Catalyst Wire Dossier Catalyst Wire Dossier

Hemoporfin PDT

hematoporphyrin derivative (Hemoporfin) used in photodynamic therapy · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hemoporfin PDT, covering 2020-08-13 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT [Phase 2]

See pricing